Skip to main content
Journal cover image

Survey of cryoprecipitate production and cryoprecipitate and fibrinogen concentrate utilization in North America: Variable practices observed from July 2016 to June 2021, The BEST Collaborative Study.

Publication ,  Journal Article
Lu, W; Singh, U; Ziman, A; Vassallo, R; Poisson, JL; Shih, AW; Raval, JS; Grandoni, J; Jacquot, C; Germain, M; Dunbar, NM; Cohn, C; Young, P ...
Published in: Transfusion
November 2025

BACKGROUND: Cryoprecipitated antihemophiliac factor (cryo) is primarily used to replenish fibrinogen in acquired coagulopathy. Little has been reported about its usage patterns within hospitals with respect to patient population, frequency of use, and dosing. STUDY DESIGN AND METHODS: Cryo production and usage data were collected over 5 years from July 1, 2016, to June 30, 2021, from nationally based blood collection centers in the United States (U.S. n = 2) and Canada (n = 2) and from eight large academic hospitals, respectively. Usage data for a similar product, purified fibrinogen concentrate were also collected from four hospitals. RESULTS: Two U.S. blood collectors reported increases in cryo production normalized to total whole blood collections from 17.4% in 2016 to 22.3% in 2021 and from 16.4% in 2016 to 20.2% in 2021. In contrast, in Canada cryo manufacturing increased slightly in one region (11.3%-12.9%) and decreased (8.0%-2.0%) in the other. Cryo utilization, defined as numbers of patients treated normalized to the inpatient census, and dose administered per patient did not consistently increase and differed significantly between hospitals participating in the study (p < .0001). Likewise, the departments that most frequently transfused cryo varied between hospitals. Similarly, variations in practice were observed for fibrinogen concentrate usage. CONCLUSION: While much of Canada and Europe have moved towards using fibrinogen concentrate, two large U.S. collectors have increased cryo distribution. The lack of standardization and variability in the clinical practice regarding the use of cryo and fibrinogen concentrate reported by study sites may be attributable to practitioner preference, availability, and/or cost rather than adherence to published evidence or guidelines.

Duke Scholars

Published In

Transfusion

DOI

EISSN

1537-2995

Publication Date

November 2025

Volume

65

Issue

11

Start / End Page

2091 / 2104

Location

United States

Related Subject Headings

  • United States
  • Surveys and Questionnaires
  • North America
  • Humans
  • Fibrinogen
  • Factor VIII
  • Cardiovascular System & Hematology
  • Canada
  • 3204 Immunology
  • 3202 Clinical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Lu, W., Singh, U., Ziman, A., Vassallo, R., Poisson, J. L., Shih, A. W., … Biomedical Excellence for Safer Transfusion Collaborative. (2025). Survey of cryoprecipitate production and cryoprecipitate and fibrinogen concentrate utilization in North America: Variable practices observed from July 2016 to June 2021, The BEST Collaborative Study. Transfusion, 65(11), 2091–2104. https://doi.org/10.1111/trf.18434
Lu, Wen, Umesh Singh, Alyssa Ziman, Ralph Vassallo, Jessica L. Poisson, Andrew W. Shih, Jay S. Raval, et al. “Survey of cryoprecipitate production and cryoprecipitate and fibrinogen concentrate utilization in North America: Variable practices observed from July 2016 to June 2021, The BEST Collaborative Study.Transfusion 65, no. 11 (November 2025): 2091–2104. https://doi.org/10.1111/trf.18434.
Lu W, Singh U, Ziman A, Vassallo R, Poisson JL, Shih AW, Raval JS, Grandoni J, Jacquot C, Germain M, Dunbar NM, Cohn C, Young P, Biomedical Excellence for Safer Transfusion Collaborative. Survey of cryoprecipitate production and cryoprecipitate and fibrinogen concentrate utilization in North America: Variable practices observed from July 2016 to June 2021, The BEST Collaborative Study. Transfusion. 2025 Nov;65(11):2091–2104.
Journal cover image

Published In

Transfusion

DOI

EISSN

1537-2995

Publication Date

November 2025

Volume

65

Issue

11

Start / End Page

2091 / 2104

Location

United States

Related Subject Headings

  • United States
  • Surveys and Questionnaires
  • North America
  • Humans
  • Fibrinogen
  • Factor VIII
  • Cardiovascular System & Hematology
  • Canada
  • 3204 Immunology
  • 3202 Clinical sciences